Process View
0 genes annotated in mouse
DOID:0050539
In addition to gene-name show these genes:
Disease predictions are made from cross-annotation of human disease genes to the identified functional analogs in mouse and predicted with the mouse functional network.
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
Aars | alanyl-tRNA synthetase | 0.385 | Human | |
Nars | asparaginyl-tRNA synthetase | 0.226 | ||
Gars | glycyl-tRNA synthetase | 0.197 | Human | |
Bag3 | BCL2-associated athanogene 3 | 0.145 | ||
Asns | asparagine synthetase | 0.137 | ||
Sars | seryl-aminoacyl-tRNA synthetase | 0.110 | ||
Ywhaz | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.108 | ||
Yars | tyrosyl-tRNA synthetase | 0.099 | ||
Lrrc59 | leucine rich repeat containing 59 | 0.087 | ||
Plec | plectin | 0.083 | ||
Eif3c | eukaryotic translation initiation factor 3, subunit C | 0.075 | ||
Iars | isoleucine-tRNA synthetase | 0.049 | ||
Mars | methionine-tRNA synthetase | 0.048 | ||
Egfr | epidermal growth factor receptor | 0.042 | ||
Dctn1 | dynactin 1 | 0.041 | ||
Lars | leucyl-tRNA synthetase | 0.032 | ||
Tnfrsf12a | tumor necrosis factor receptor superfamily, member 12a | 0.026 | ||
Slc3a2 | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 | 0.024 | ||
Rxra | retinoid X receptor alpha | 0.024 | ||
Mthfd2 | methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase | 0.023 | ||
Eif3d | eukaryotic translation initiation factor 3, subunit D | 0.022 | ||
Nos3 | nitric oxide synthase 3, endothelial cell | 0.022 | ||
Atf4 | activating transcription factor 4 | 0.020 | ||
Itga3 | integrin alpha 3 | 0.019 | ||
Tinagl1 | tubulointerstitial nephritis antigen-like 1 | 0.019 | ||
Psmd3 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 3 | 0.019 | ||
Ank | progressive ankylosis | 0.019 | ||
Bmpr2 | bone morphogenic protein receptor, type II (serine/threonine kinase) | 0.017 | ||
Larp1 | La ribonucleoprotein domain family, member 1 | 0.017 | ||
Slc7a5 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 | 0.017 | ||
Fbn1 | fibrillin 1 | 0.016 | ||
Spna2 | spectrin alpha 2 | 0.016 | ||
Slc12a4 | solute carrier family 12, member 4 | 0.016 | ||
Col1a1 | collagen, type I, alpha 1 | 0.016 | ||
Ptpn11 | protein tyrosine phosphatase, non-receptor type 11 | 0.015 | ||
Ddb1 | damage specific DNA binding protein 1 | 0.015 | ||
Myh9 | myosin, heavy polypeptide 9, non-muscle | 0.014 | ||
Psat1 | phosphoserine aminotransferase 1 | 0.014 | ||
Snta1 | syntrophin, acidic 1 | 0.014 | ||
P4ha2 | procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide | 0.013 | ||
Pparg | peroxisome proliferator activated receptor gamma | 0.013 | ||
Csda | cold shock domain protein A | 0.013 | ||
Macf1 | microtubule-actin crosslinking factor 1 | 0.013 | ||
Nfe2l1 | nuclear factor, erythroid derived 2,-like 1 | 0.012 | ||
Edn1 | endothelin 1 | 0.012 | ||
Sh3pxd2b | SH3 and PX domains 2B | 0.012 | ||
Rrp12 | ribosomal RNA processing 12 homolog (S. cerevisiae) | 0.012 | ||
Itgb1 | integrin beta 1 (fibronectin receptor beta) | 0.012 | ||
Vhl | von Hippel-Lindau tumor suppressor | 0.012 | ||
Tars | threonyl-tRNA synthetase | 0.012 | ||
Mmp14 | matrix metallopeptidase 14 (membrane-inserted) | 0.012 | ||
Cebpb | CCAAT/enhancer binding protein (C/EBP), beta | 0.011 | ||
Sec31a | Sec31 homolog A (S. cerevisiae) | 0.011 | ||
Cav1 | caveolin 1, caveolae protein | 0.011 | ||
Ipo4 | importin 4 | 0.011 | ||
Vcp | valosin containing protein | 0.011 | ||
Akt1 | thymoma viral proto-oncogene 1 | 0.011 | ||
Cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 0.011 | ||
Kcnma1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 | 0.011 | ||
Wnt4 | wingless-related MMTV integration site 4 | 0.011 | ||
2310046A06Rik | RIKEN cDNA 2310046A06 gene | 0.011 | ||
Serpine1 | serine (or cysteine) peptidase inhibitor, clade E, member 1 | 0.010 | ||
Mll3 | myeloid/lymphoid or mixed-lineage leukemia 3 | 0.010 | ||
Atf5 | activating transcription factor 5 | 0.010 |